Smith David Ross
CIK 0001650274
Corporate Executive VP & CFODirector
Filings
9
Latest Jun 12, 2025
Issuers covered
2
Showing
9 of 9
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 0% | -1.1% | -1.1% | -1.1% | -1.1% |
| 90 days | 5 | 100% | +19.2% | +19.2% | +19.2% | +19.2% |
| 180 days | 5 | 100% | +27.7% | +27.7% | +27.7% | +27.7% |
| 365 days | 5 | 100% | +18.4% | +18.4% | +18.4% | +18.4% |
Issuers
Companies where Smith David Ross has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| FTRE | Fortrea Holdings Inc. | 5 | Jun 12, 2025 |
| CRL | Charles River Laboratories International, Inc. | 4 | Mar 4, 2022 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|